Heterogeneous cell response to topotecan in a CFSE-based proliferation test

Area of Science:

• Cell Biology
• Pharmacology
• Biotechnology

Background:

• Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a vital tool for tracking cell division and migration.
• CFSE partitioning leads to predictable fluorescence decay across cell generations.
• Inter-cell variability in CFSE loading complicates analysis, especially in cancer cell lines.

Purpose of the Study:

• To develop and assess refined experimental and data analysis procedures for CFSE-based antiproliferative drug activity measurement in cancer cell lines.
• To address the limitations of CFSE analysis caused by inter-cell variability in loading and peak overlap.

Main Methods:

• Utilized IGROV1 ovarian cancer cells loaded with CFSE.
• Applied topotecan, an anticancer drug, and evaluated its effects on cell division.
• Implemented a CFSE efflux evaluation procedure to stabilize peak positions.
• Fitted CFSE histograms using Gaussian distributions to represent distinct cell generations.
• Combined flow cytometry data with Coulter counter absolute cell counts for comprehensive analysis.

Main Results:

• Monitored the time-course of cell division, including undivided cells and those entering subsequent cycles after topotecan treatment.
• Developed an algorithm to estimate the 96-hour outcome of the initial cell population, quantifying undivided, dividing, and dead cells.
• Demonstrated the feasibility of achieving quantitative antiproliferative activity measurements.

Conclusions:

• Established robust experimental and data analytic procedures for CFSE-based antiproliferative drug screening in cancer cell lines.
• Achieved a quantitative level of measurement, though it necessitates stringent control over experimental data.
• Highlighted the challenges and requirements for precise CFSE analysis in cancer research.